Projects per year
Fingerprint
Dive into the research topics where Mark E Mailliard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cost-effectiveness of universal and targeted hepatitis C virus screening in the United States
Tatar, M., Keeshin, S. W., Mailliard, M. & Wilson, F. A., Sep 3 2020, In: JAMA Network Open. 3, 9, e202015756.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study
Feld, J. J., Maan, R., Zeuzem, S., Kuo, A., Nelson, D. R., Di Bisceglie, A. M., Manns, M. P., Sherman, K., Frazier, L. M., Sterling, R., Mailliard, M., Schmidt, M., Akushevich, L., Vainorius, M. & Fried, M. W., Sep 15 2016, In: Clinical Infectious Diseases. 63, 6, p. 776-783 8 p.Research output: Contribution to journal › Article › peer-review
Open Access39 Scopus citations -
Effectiveness of Simeprevir Plus Sofosbuvir, with or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection
HCV-TARGET Study Group, Feb 1 2016, In: Gastroenterology. 150, 2, p. 419-429 11 p.Research output: Contribution to journal › Article › peer-review
Open Access150 Scopus citations -
Spontaneous intramural duodenal hematoma in type 2B von Willebrand disease
Eichele, D. D., Ross, M., Tang, P., Hutchins, G. F. & Mailliard, M., Nov 7 2013, In: World Journal of Gastroenterology. 19, 41, p. 7205-7208 4 p.Research output: Contribution to journal › Article › peer-review
14 Scopus citations -
Boceprevir for untreated chronic HCV genotype 1 infection
SPRINT-2 Investigators, Mar 31 2011, In: New England Journal of Medicine. 364, 13, p. 1195-1206 12 p.Research output: Contribution to journal › Article › peer-review
1275 Scopus citations